2016-09-12 13:09:21 UTC

Improve Outcomes for Your IBD and HCV Patients

Sept. 12, 2016

Recorded webcast now available for physicians who are looking to gain CME and improve patient care.

Take advantage of a free CME webcast developed by AGA, PRIME® and the Academy of Managed Care Pharmacy® to develop a more collaborative approach to treating patients with HCV and IBD.

Experts in HCV, IBD and managed care pharmacy present their perspectives and lead participants in this recorded webcast (from workshops across the U.S.) to discuss the latest clinical evidence and identify strategies to improve interprofessional communication, navigate managed care requirements and leverage resources to improve patient outcomes.

Along with CME, participants will walk away with a better understanding of payor and provider perspectives, as well as actionable knowledge to help decrease unnecessary claims denials, address gaps in the understanding of managed care policies, and improve the communication of patient information and evidence to managed care organizations. 

Physicians completing the program, which takes about an hour to complete, will earn AMA PRA Category 1 Credit™ classified as enduring material. Take the course.

More on Continuing Education

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Jan. 9, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Comprehensive Update of Biosimilar Therapies: Your Questions Answered

Dec. 11, 2017

Gain a better understanding of the evidence currently available on biosimilars for IBD and how to educate/discuss biosimilars with patients.